主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
MGNX
#3182
MacroGenics, Inc.
1.9
9
+1.53%
版块:
基础:
利润货币:
日范围
年范围
日变化
+1.53%
每月变动
+8.15%
6个月变化
+13.71%
年变化
-17.43%
前一天收盘价
1.9
6
Open
1.9
9
Bid
Ask
Low
1.9
9
High
1.9
9
交易量
16
市场
股票
医疗保健
MGNX
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
新闻
BioLife Solutions, Inc. (BLFS) Surpasses Q4 Earnings and Revenue Estimates
MacroGenics hisseleri FDA’nın kısmi klinik durdurma kararıyla düştü
MacroGenics stock falls after FDA places partial clinical hold
Why Is MacroGenics Stock Sinking Tuesday? - Macrogenics (NASDAQ:MGNX)
Sanofi's Teizeild Gets EU Approval for Treating Type 1 Diabetes
FDA Accepts SNY Filing for Expanded Use of T1D Drug in Young Children
Thanksgiving: Top 10 Most Innovative BioPharma Drugs In Phase 3
MacroGenics (MGNX) Q3 Earnings and Revenues Surpass Estimates
MacroGenics Inc kazancı $0,68 ile beklentilere göre daha iyi, kâr ise beklentilere göre yüksek
MacroGenics Inc earnings beat by $0.68, revenue topped estimates
MacroGenics (MGNX) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
Stryker (SYK) Q3 Earnings and Revenues Beat Estimates